Video

Q&A With Craig Strasnick From Commonwealth Laboratories: New Test Looks for Fast Identification of Irritable Bowel Syndrome

Author(s):

Whether patients have irritable bowel syndrome or inflammatory bowel disease what matters to them most is getting the correct diagnosis and treatment as quickly as possible.

Whether patients have irritable bowel syndrome or inflammatory bowel disease what matters to them most is getting the correct diagnosis and treatment as quickly as possible.

Craig Strasnick, Chief Operating Officer of Commonwealth Laboratories discussed IBS Check, a new method for diagnosing the condition and separating the two possible diagnoses in an effort to give patients the best results. Strasnick said an "exclusionary pathway" has been used in the past which can often require medical procedures and can take longer before getting the final and correct diagnosis.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Christine Frissora, MD | Credit: Weill Cornell
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
© 2024 MJH Life Sciences

All rights reserved.